The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Tue., Jan. 26, 6:21 AM

Slide #4. Dyne Therapeutics, Inc. Secondary Offering

Company: Dyne Therapeutics, Inc. (NASDAQ:DYN)
Date announced: 1/20/2021
Shares Offered: 6,000,000
Date of Pricing: 1/20/2021
Price Per Share: $28.00
Secondary Offering Details: Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $28.00 per share. In addition, Dyne has granted the underwriters a 30-day option to purchase up to 900,000 additional shares of common stock at the public offering price, less the underwriting discount and commissions. All of the shares are being offered by Dyne.

Dyne Therapeutics is a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. Co. offers its services in the United States.

Preferred: DYN.PRA


Open the DYN Page at The Online Investor »

Company Name:  Dyne Therapeutics Inc
Stock buyback:  DYN buyback
Website:  www.dyne-tx.com
Sector:  Biotechnology
Number of ETFs Holding DYN:  7
Total Market Value Held by ETFs:  $17.46M
Total Market Capitalization:  $965.00M
% of Market Cap. Held by ETFs:  1.81%
 

Open the DYN Page at The Online Investor (in a new window) »

January 26, 2021    6:21 AM Eastern
Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
94th percentile
(ranked higher than approx. 94% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2021, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.